MG
HALO icon

Mather Group’s Halozyme HALO Stock Holding History

Mather Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Buy
+278
New +$19.6K ﹤0.01% 1302
2025
Q4 		– Sell
-197
Closed -$14.4K – 1059
2025
Q3 		$14.4K Buy
+197
New +$13.1K ﹤0.01% 1188
2025
Q2 		– Sell
-197
Closed -$12.6K – 1069
2025
Q1 		$12.6K Buy
197
+70
+55% +$4.07K ﹤0.01% 1194
2024
Q4 		$6.07K Hold
127
– – ﹤0.01% 1343
2024
Q3 		$7.27K Sell
127
-125
-50% -$7.17K ﹤0.01% 1233
2024
Q2 		$10.3K Buy
252
+47
+23% +$2.06K ﹤0.01% 1448
2024
Q1 		$7.58K Buy
+205
New +$7.68K ﹤0.01% 1271

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mather Group's HALO Position: Q1 2026 in Review

Mather Group opened a new position in Halozyme (HALO) in Q1 2026: 278 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #1302 among its holdings. This is a return to the name: Mather Group previously reported a position in HALO as recently as Q3 2025.

Mather Group first reported a position in HALO in Q1 2024 and has held it in 7 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Mather Group held 278 shares of Halozyme worth $18K as of Q1 2026.
  • Halozyme was a new Mather Group position in Q1 2026.
  • Halozyme made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1302 holding.
  • Mather Group first reported a position in Halozyme in Q1 2024 and has held it in 7 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.